InvestorsHub Logo
Followers 18
Posts 908
Boards Moderated 0
Alias Born 09/28/2014

Re: beartrap12 post# 247864

Thursday, 10/17/2019 8:39:22 AM

Thursday, October 17, 2019 8:39:22 AM

Post# of 708967

“They only have one shot, and partnering or selling out early, may have killed DCVaxL. Most big business would rather buy a competitor for pennies on the dollar and hide the product if it is a disruptive one.” - Beartrap12




Review recent example:

“SAN DIEGO, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") announced today that a Los Angeles Superior Court judge has rejected Patrick Soon-Shiong’s attempt to allow him and his company, NantPharma, to avoid the billion-dollar fraud and breach of contract claims that Sorrento filed against them earlier this year. Sorrento’s claims relate to the “catch and kill” scheme that Soon-Shiong allegedly orchestrated to keep Sorrento’s promising cancer drug, Cynviloq, off the market in order to preserve Soon-Shiong’s personal financial interest in another competing drug.”

https://www.biospace.com/article/releases/los-angeles-court-rejects-patrick-soon-shiong-s-attempt-to-avoid-sorrento-litigation-allowing-arbitration-case-to-move-forward/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News